Abstract
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, which encodes an ATP-dependent anion channel. Disease-causing mutations can affect channel biogenesis, trafficking or function, and result in reduced ion transport at the apical surface of many tissues. The most common CFTR mutation is a deletion of phenylalanine at position 508 (F508), which results in a misfolded protein that is prematurely targeted for degradation. This article focuses on how proteomic approaches have been utilized to explore the mechanisms of premature proteolysis in CF. Additionally, we emphasize the potential for proteomic-based technologies in expanding our understanding of CF pathophysiology and therapeutic approaches.
Original language | English (US) |
---|---|
Pages (from-to) | 473-486 |
Number of pages | 14 |
Journal | Expert Review of Proteomics |
Volume | 7 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2010 |
Externally published | Yes |
Keywords
- CFTR
- CFTR biogenesis
- absolute quantification method
- cystic fibrosis
- interactomics
- proteolysis
- proteomics
- ubiquitination
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology